Commercialization Roadmap Advisory Service™

Build Your Commercialization Strategy Before You Pursue Funding

Every Successful Commercialization Begins with a Plan

Commercialization planning should come before grant writing, investor outreach, company formation, or licensing discussions. A Strategic Commercialization Playbook helps answer the key questions that guide every future commercialization decision.

This Is an Advisory Service

This is not simply a writing service. You bring the scientific expertise while Bootstrap Your Biotech provides commercialization strategy and guidance. You complete a structured commercialization planning questionnaire that forms the framework for the playbook. You are not expected to know every answer—that is where the advisory process creates value.

How the Process Works

  1. Complete the commercialization planning questionnaire.
  2. Participate in a 60-minute Commercialization Strategy Call.
  3. Bootstrap Your Biotech performs independent commercialization research.
  4. Receive your customized commercialization playbook.
  5. Meet for a 30-minute roadmap review. One revision is included.

What You'll Receive

  • Technology assessment
  • Commercial opportunity evaluation
  • Target customer analysis
  • Competitive landscape
  • Preliminary IP considerations
  • Regulatory pathway discussion
  • Commercialization milestones
  • Validation strategy
  • Recommended funding sequence
  • Licensing vs. startup framework
  • Strategic partnership opportunities
  • Immediate action plan

After Completing Your Commercialization Roadmap Advisory ServiceTM, You'll Have

  • A commercialization strategy
  • Clear development priorities
  • Recommended funding sequence
  • Better investor readiness
  • Better SBIR preparation
  • More confidence in commercialization decisions


Our Commercialization Roadmap Advisory Service™ helps you build a customized commercialization roadmap that becomes the foundation for every major commercialization decision.


  • Customized to your technology
  • Collaborative advisory process
  • Designed for researchers

Founder Pricing

$750.00 – One-time


Comparable strategic consulting engagements often range from $5,000–$10,000.

Purchase Today

No hourly consulting fees. No surprise invoices.

What's the Cost of Not Having a Commercialization Strategy?

Researchers routinely invest thousands—or even tens of thousands—of dollars in patent filings, grant preparation, regulatory consulting, company formation, and prototype development.


A commercialization roadmap helps ensure those investments are made in the right order and support a clear path to commercialization.


Sometimes the most valuable investment isn't the largest one—it's the one that helps you avoid costly missteps.

Technology Transfer Office Funding

Some universities and research institutions have commercialization support funds through their Technology Transfer Office (TTO) or translational research programs that may reimburse commercialization planning or mentoring services. Availability varies by institution, so researchers should check with their TTO.

Who This Is For

  • University researchers
  • Hospital researchers
  • NIH-funded investigators
  • NSF-funded investigators
  • SBIR/STTR applicants
  • Technology transfer spinouts
  • First-time biotech founders

Who This Is Not For

This service may not be the best fit if:


  • You already have a comprehensive commercialization strategy that has been validated.
  • You're looking only for grant writing without broader commercialization planning.
  • Your technology is still at a stage where there is not yet enough information to evaluate commercialization pathways.

 

If you're unsure, start with the complimentary consultation.

Frequently Asked Questions

  • How long does the process take?

    Most projects are completed within 2 weeks after the strategy session, depending on responsiveness and project complexity.

  • Do I need to have a company formed?

    No. Many clients are still at the university or hospital research stage.

  • Can this roadmap support future SBIR/STTR applications?

    Yes. While it is not a grant application, it is designed to help clarify the commercialization strategy that can inform future grant proposals.

  • Will you write the roadmap for me?

    The roadmap is developed collaboratively. You contribute the scientific and technical knowledge, and Bootstrap Your Biotech contributes commercialization strategy and guidance.

Illustrative Commercialization Journeys (Case Studies)

See How Different Technologies Follow Different Commercialization Paths

Medical Device: From Great Engineering to a Stronger SBIR Strategy

Starting Point

A university engineering team developed a minimally invasive medical device that demonstrated excellent laboratory performance.


The researchers planned to immediately prepare an NIH SBIR Phase I application.


During the Commercialization Roadmap Advisory Session™, several important questions emerged:


  • Who is the actual customer? 
  • Who ultimately pays for the device?
  • What clinical evidence would investors expect after Phase I?
  • Is FDA clearance likely through the 510(k) pathway or De Novo? 
  • Which milestones would create the greatest increase in company value? 


Rather than immediately writing the grant, we first developed a commercialization strategy.


Roadmap Recommendations

The roadmap identified several high-priority actions:

✓ Interview physicians and hospital purchasing personnel

✓ Confirm reimbursement considerations

✓ Define the regulatory pathway

✓ Complete a small clinical usability study before large-scale validation

✓ Build commercialization milestones around future value inflection points

✓ Align the future SBIR proposal with commercialization objectives


Potential Outcome

Instead of simply submitting a grant application, the research team entered the funding process with:


  • A clearer commercialization strategy 
  • Better-defined milestones/AIMS
  • A stronger value proposition
  • A roadmap supporting future licensing or startup formation 


Key Takeaway

The commercialization roadmap helped ensure that the future grant application supported a broader commercialization strategy—not just a research project.


Therapeutic: Preserving Founder Equity Through Better Planning

Starting Point

A university researcher had discovered a promising therapeutic platform.


The initial plan was to form a company and begin seeking venture capital.


The technology was scientifically exciting—but commercialization planning revealed several opportunities to reduce risk before pursuing investors.


Roadmap Recommendations

Together we identified a commercialization strategy that focused on:

✓ Completing additional proof-of-concept studies

✓ Building a stronger intellectual property position

✓ Pursuing non-dilutive funding before equity financing

✓ Identifying disease foundations that aligned with the technology

✓ Sequencing future milestones around valuation growth

✓ Delaying institutional investment until key technical risks were reduced


Potential Outcome

Rather than raising capital immediately, the founders focused on increasing the value of the technology first.


This approach helped position future financing discussions from a stronger negotiating position and reduced the likelihood of unnecessary early dilution.


Key Takeaway

A commercialization roadmap helps researchers understand not only how to raise funding—but when it may make the most strategic sense to do so.


Diagnostic: Building a Commercialization Strategy Before Pursuing an SBIR

Starting Point

A research team developed a novel molecular diagnostic platform.


The initial assumption was that the next step should be an NIH SBIR application.


During commercialization planning, several strategic questions emerged:

  • Which customer segment should be targeted first?
  • Is the technology best suited for hospital laboratories, physician offices, or point-of-care testing?
  • What validation studies would provide the greatest commercial value?
  • Which reimbursement pathway appeared most favorable?
  • Would strategic partnerships accelerate commercialization?


Rather than immediately writing the grant, we first developed a commercialization strategy.


Roadmap Recommendations

The commercialization roadmap focused on:

✓ Defining the first commercial market

✓ Prioritizing customer discovery

✓ Sequencing analytical and clinical validation

✓ Identifying strategic corporate partnerships

✓ Aligning commercialization milestones with future funding opportunities

✓ Building a commercialization strategy before writing the SBIR application


Potential Outcome

The resulting roadmap provided a clearer commercialization pathway that could guide future grant applications, partnership discussions, and investor conversations.


Key Takeaway

Strong commercialization planning helps transform a promising scientific discovery into a technology with a practical path toward market adoption.


Ready to build your commercialization strategy?

Purchase Today

Not ready yet?


Book a complimentary 15-minute Commercialization Strategy Call to discuss your technology and determine whether this service is the right next step.

Schedule My Free 15-Minute Strategy Call

  • Commercialization Roadmap Advisory Service Disclaimer

    The Bootstrap Your Biotech™ Commercialization Roadmap Advisory Service is an educational and strategic advisory service intended to assist researchers, entrepreneurs, startups, and early-stage biotechnology companies in evaluating commercialization opportunities and developing a high-level commercialization strategy.


    Recommendations provided during the advisory session are based on information supplied by the client, publicly available information, and the professional experience and judgment of Bootstrap Your Biotech. Commercialization outcomes depend on numerous factors beyond our control, including scientific progress, regulatory requirements, market conditions, financing availability, competitive activity, intellectual property, and execution by the client.


    This advisory service does not constitute legal, accounting, tax, investment, securities, valuation, engineering, regulatory, clinical, or intellectual property advice. Clients should consult qualified attorneys, certified public accountants, patent counsel, regulatory specialists, reimbursement experts, and other professional advisors before making business, financial, legal, or regulatory decisions.


    Bootstrap Your Biotech does not guarantee:

    • Receipt of grant funding (including SBIR/STTR or other non-dilutive funding)
    • Investment or financing
    • Commercial partnerships or licensing agreements
    • Regulatory approval
    • Commercial success or profitability
    • Specific business, financial, or scientific outcomes

    Any estimates regarding costs, timelines, market size, funding opportunities, reimbursement pathways, valuation, commercialization milestones, or probability of success are provided for planning purposes only and should not be relied upon as guarantees or definitive projections.


    Unless otherwise agreed in writing, all materials prepared by Bootstrap Your Biotech remain the intellectual property of Bootstrap Your Biotech. Clients are granted a non-exclusive license to use deliverables internally for their own commercialization planning and business development activities.


    Clients remain solely responsible for all strategic, financial, operational, regulatory, scientific, and business decisions made before, during, or after the advisory engagement.


    By participating in the Commercialization Roadmap Advisory Service, the client acknowledges that they have read, understood, and accepted the terms of this disclaimer.

Have questions about our company formation services?

Talk to Mike today!

(602) 905-4611